ASP Isotopes Sees Unusually High Options Volume (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of some unusual options trading activity on Tuesday. Stock investors bought 15,098 call options on the company. This is an increase of 65% compared to the typical daily volume of 9,140 call options.

Insider Activity at ASP Isotopes

In related news, COO Robert Ainscow sold 22,500 shares of the stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $5.21, for a total value of $117,225.00. Following the sale, the chief operating officer directly owned 1,490,317 shares of the company’s stock, valued at approximately $7,764,551.57. This represents a 1.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Heather Kiessling sold 23,124 shares of the stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total transaction of $126,719.52. Following the completion of the sale, the chief financial officer directly owned 709,376 shares in the company, valued at approximately $3,887,380.48. The trade was a 3.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 90,704 shares of company stock valued at $463,252. Insiders own 14.40% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Rovida Investment Management Ltd lifted its holdings in shares of ASP Isotopes by 45.5% during the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock worth $30,688,000 after acquiring an additional 1,000,000 shares during the period. Caprock Group LLC purchased a new position in shares of ASP Isotopes during the 3rd quarter worth about $2,747,000. SPX Gestao de Recursos Ltda purchased a new position in shares of ASP Isotopes during the 3rd quarter worth about $1,054,000. Rathbones Group PLC lifted its holdings in shares of ASP Isotopes by 68.6% during the 4th quarter. Rathbones Group PLC now owns 399,599 shares of the company’s stock worth $2,138,000 after acquiring an additional 162,535 shares during the period. Finally, Tudor Investment Corp ET AL lifted its holdings in shares of ASP Isotopes by 37.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 460,685 shares of the company’s stock worth $4,432,000 after acquiring an additional 125,687 shares during the period. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ASPI has been the topic of several analyst reports. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research note on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Friday, March 27th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Trading Up 19.6%

Shares of ASP Isotopes stock traded up $1.09 during mid-day trading on Tuesday, hitting $6.64. 7,794,652 shares of the stock were exchanged, compared to its average volume of 4,999,316. ASP Isotopes has a twelve month low of $3.92 and a twelve month high of $14.49. The stock has a market capitalization of $835.98 million, a price-to-earnings ratio of -3.19 and a beta of 3.26. The company has a 50-day simple moving average of $5.06 and a 200 day simple moving average of $5.91. The company has a current ratio of 4.39, a quick ratio of 12.20 and a debt-to-equity ratio of 0.69.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.28) by $0.06. The business had revenue of $8.36 million for the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.